文献速递临床试验与 GCP流行病学与生物统计

优化贝叶斯自适应相称设计的中期分析时机

Optimizing interim analysis timing for Bayesian adaptive commensurate designs.
PubMed 文献 · Stat Med · 2019-12-04

针对罕见病药物试验样本有限的问题,提出一种新型贝叶斯自适应相称设计,在借入历史信息的同时利用特定收益函数优化中期分析时机;通过模拟校准使算法具备可接受的长期频率学性质(I 类错误和把握度),并以罕见遗传病儿科试验设计为例展示方法,提供 optimIA R 包实现。

要点

  • 贝叶斯自适应相称设计可借入历史信息并灵活设定中期分析。
  • 收益函数权衡早期停止节省的样本量与正确早期决策概率。
  • 设计阶段通过模拟校准 I 类错误和把握度等频率学性质。

核心结论

  • 提出一种贝叶斯自适应相称设计,通过收益函数优化中期分析时机,并以模拟校准频率学性质。

研究设计与样本

  • 方法学研究,提出新型贝叶斯自适应相称设计,在设计阶段通过模拟校准长期频率学性质(I 类错误和把握度)。
  • 以罕见遗传病儿科试验设计为示例说明方法应用。

主要发现

  • 所提设计可自适应借入历史信息并利用收益函数优化中期分析时机。
  • 试验收益是早期停止可节省样本量与正确早期决策(无效或有效)概率的函数。
  • 通过模拟校准使贝叶斯算法具备可接受的长期频率学性质(I 类错误和把握度)。

临床怎么用

  • 在罕见病药物试验设计中,可考虑用该设计优化中期分析时机以提升统计效率并降低研发成本与伦理风险。
  • 可通过 optimIA R 包(https://github.com/wxwx1993/Bayesian_IA_Timing)实现该方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In developing products for rare diseases, statistical challenges arise due to the limited number of patients available for participation in drug trials and other clinical research. Bayesian adaptive clinical trial designs offer the possibility of increased statistical efficiency, reduced development cost and ethical hazard prevention via their incorporation of evidence from external sources (historical data, expert opinions, and real-world evidence), and flexibility in the specification of interim looks. In this paper, we propose a novel Bayesian adaptive commensurate design that borrows adaptively from historical information and also uses a particular payoff function to optimize the timing of the study's interim analysis. The trial payoff is a function of how many samples can be saved via early stopping and the probability of making correct early decisions for either futility or efficacy. We calibrate our Bayesian algorithm to have acceptable long-run frequentist properties (Type I error and power) via simulation at the design stage. We illustrate our approach using a pediatric trial design setting testing the effect of a new drug for a rare genetic disease. The optimIA R package available at https://github.com/wxwx1993/Bayesian_IA_Timing provides an easy-to-use implementation of our approach.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Wu X, Xu Y, Carlin BP, et al. Optimizing interim analysis timing for Bayesian adaptive commensurate designs. Stat Med. 2019. PMID: 31799737. doi:10.1002/sim.8414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。